Benaroya Research Institute: Zura Bio, BRI enter sponsored research agreement focussed on characterizing the pivotal role of IL7Ra in TSLP and IL7 signalling pathways

Zura Bio Limited, a multi─asset clinical─stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, and Benaroya Research Institute (BRI), a Seattle based non─